Evaluation of a New Self-Assessed, Home-Based Symptom Score Test in Cat Allergic Patients

July 1, 2015 updated by: University of Zurich
The purpose of this study is to better standardize the symptom recording of cat allergic persons under real-life conditions. A new self-assessed, home-based symptom score will be tested.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In order to bring research on cat dander allergy a step further we aim to investigate cat dander allergy symptoms and record them in a natural environment, respectively, i.e. at the participant's home. For this purpose we aim to test a new self-assessed, homebased symptom score (called HypoScore). The participants will perform 8 provocation tests. Every provocation test consists of petting the cat until the participants become symptomatic. The participants have to pet the cat everytime in the same manner. Directly before and after the provocation test the symptoms will be recorded in the eCRF by using an iPad mini.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zurich, Switzerland, 8091
        • Clinical Trial Center of the University Hospital Zurich

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participant understands the nature, meaning and scope of the study.
  • Signed Informed Consent after being informed.
  • Male and Female patients 18 years to 65 years of age.
  • Positive screening prick test (mean wheal diameter ≥ 3 mm) when tested with already standardized cat allergen extract.
  • Positive screening prick test (wheal diameter ≥ 3mm) to Histamine dihydrochloride 10mg/ml.
  • Positive Scratch Test when tested with cat dander sample of participant's cat.
  • Baseline symptoms with a severity of at least "1" in minimal 2 various symptoms.
  • Owner of a cat that lives in the same household.

Exclusion Criteria:

  • Impaired in understanding the nature, meaning and scope of the study or incapable of giving written informed consent
  • Participation in another study with investigational drug within the 30 days preceding and during the present study
  • Women who are pregnant or breast feeding
  • Intention to become pregnant during the course of the study
  • Positive skin reaction in the prick test to negative control
  • History of anaphylactic reaction to pet allergens
  • Severe diseases influencing the results of the present study by discretion of the investigator
  • Immunotherapy with fel d 1 / cat allergen preparation during the past two years
  • Skin lesions and excessive hair-growth in the skin test areas
  • Treatment with prohibited concomitant medications with the exception of medications with local effects which will not influence the results of the skin tests and the results of the other tests (testing period).
  • The patient should not suffer from other respiratory allergies during this study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HypoScore
Provocation test. Recording symptoms of cat allergic participants with the cat owner's cat: Before and after petting the cat.
The participants will perform 8 provocation tests. Every provocation test consists of petting the cat until the participants become symptomatic. The symptoms of cat allergic participants with the cat owner's cat will be recorded before and after petting the cat.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time until the participant becomes symptomatic
Time Frame: approx. 15 minutes (during Provocation Test)
How long can the owner pet his/her cat until he becomes symptomatic?
approx. 15 minutes (during Provocation Test)

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of score points resulting from symptom score recording before and after the provocation test.
Time Frame: approx. 15 minutes (before and after provocation)
approx. 15 minutes (before and after provocation)
Visual Analogue Scale Values
Time Frame: approx. 5 minutes (before provocation)
approx. 5 minutes (before provocation)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas M. Kündig, PD Dr. med., University of Zurich

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

March 17, 2015

First Submitted That Met QC Criteria

March 25, 2015

First Posted (Estimate)

March 26, 2015

Study Record Updates

Last Update Posted (Estimate)

July 2, 2015

Last Update Submitted That Met QC Criteria

July 1, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ZU-HypoScore-001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cat Allergy

Clinical Trials on Provocation test

Subscribe